Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Novagali Pharma completes €19.7mm Euronext IPO on second try

Executive Summary

Ophthalmic biotech Novagali Pharma SA netted €19.7mm ($25.5mm) in an IPO on the NYSE Euronext Paris Exchange selling 6.5mm shares (including the overallotment) at €3.40. The company had originally planned to offer 5mm shares, but increased the number of shares after the pricing ended up far below its estimated €5.80-6.80 range.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
      • Topical Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies